BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Djebbi A, Triki H, Bahri O, Cheikh I, Sadraoui A, Ben Ammar A, Dellagi K. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol Infect. 2003;130:501-505. [PMID: 12825736 DOI: 10.1017/s095026880300846x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Aissa Larousse J, Trimoulet P, Recordon Pinson P, Tauzin B, Azzouz MM, Ben Mami N, Cheikh I, Triki H, Fleury H. Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia. Virol J 2015;12:84. [PMID: 26047611 DOI: 10.1186/s12985-015-0318-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Alashek W, Altagdi M. Risk factors and genotypes of hepatitis C virus infection in libyan patients. Libyan J Med. 2008;3:162-165. [PMID: 21499468 DOI: 10.4176/080425] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kchouk FH, Gorgi Y, Bouslama L, Sfar I, Ayari R, Khiri H, Halfon P, Aouadi H, Jendoubi Ayed S, Ayed K. Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol. 2013;26:40-48. [PMID: 23374151 DOI: 10.1089/vim.2012.0043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AEE, Mestiri H, Benazzouz M, Khalfallah T, Afifi R, Elkihal L, Berkane S, Marchio A, Debzi N, Dejean A, Pineau P, Triki H, Benjelloun S. First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 2011; 3(1): 24-30 [PMID: 21307984 DOI: 10.4254/wjh.v3.i1.24] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
5 Elasifer HA, Agnnyia YM, Al-Alagi BA, Daw MA. Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol J. 2010;7:317. [PMID: 21073743 DOI: 10.1186/1743-422x-7-317] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rajhi M, Mejri S, Djebbi A, Chouaieb S, Cheikh I, Ben Yahia A, Sadraoui A, Hammami W, Azouz M, Ben Mami N, Triki H. Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes. Virus Genes 2014;48:209-17. [PMID: 24272697 DOI: 10.1007/s11262-013-1010-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Chouikha A, Ghrabi A, Ghodbane A, Hammemi W, Khedhiri M, Sadraoui A, Touzi H, Hassine HB, Maatoug S, Bensaoud C, Abdelhak S, Bouarrouj S, Gdoura M, Chaouachi H, Triki H. Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal. Front Microbiol 2021;12:697859. [PMID: 34385988 DOI: 10.3389/fmicb.2021.697859] [Reference Citation Analysis]
8 Djebbi A, Mejri S, Thiers V, Triki H. Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients. Eur J Epidemiol 2004;19:555-62. [PMID: 15330128 DOI: 10.1023/b:ejep.0000032348.83087.01] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Kamal SM, Mahmoud S, Hafez T, El-Fouly R. Viral hepatitis a to e in South mediterranean countries. Mediterr J Hematol Infect Dis 2010;2:e2010001. [PMID: 21415943 DOI: 10.4084/MJHID.2010.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
10 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
11 Chouikha A, Khedhiri M, Triki H, Hammemi W, Sadraoui A, Touzi H, Ben Yahia A, Chtourou A, Gargouri S, Feki Ben Rajah L, Hakim Karray H, Triki H. Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study. Arch Virol 2021;166:501-10. [PMID: 33394169 DOI: 10.1007/s00705-020-04918-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rouabhia S, Sadelaoud M, Chaabna-Mokrane K, Toumi W, Abenavoli L. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study. World J Hepatol 2013; 5(7): 393-397 [PMID: 23898373 DOI: 10.4254/wjh.v5.i7.393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
13 Kallala O, Kacem S, Fodha I, Pozzetto B, Abdelhalim T. Role of hepatitis C virus core antigen assay in hepatitis C care in developing country. Egypt Liver J 2021;11:77. [PMID: 34777874 DOI: 10.1186/s43066-021-00146-z] [Reference Citation Analysis]
14 Ksiaa Cheikhrouhou L, Lakhoua-Gorgi Y, Sfar I, Jendoubi-Ayed S, Aouadi H, Makhlouf M, Ayed K, Ben Abdallah T. Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's. World J Gastroenterol 2015; 21(35): 10150-10158 [PMID: 26401079 DOI: 10.3748/wjg.v21.i35.10150] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Halima SB, Bahri O, Maamouri N, Cheikh I, Alaya NB, Sadraoui A, Azaiez O, Azouz M, Mami NB, Triki H. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virol J 2010;7:229. [PMID: 20843308 DOI: 10.1186/1743-422X-7-229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Daw MA, El-Bouzedi A, Ahmed MO, Dau AA, Agnan MM. Hepatitis C Virus in North Africa: An Emerging Threat. ScientificWorldJournal 2016;2016:7370524. [PMID: 27610403 DOI: 10.1155/2016/7370524] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
17 El-Shabrawi MHF, Kamal NM, Mogahed EA, Elhusseini MA, Aljabri MF. Perinatal transmission of hepatitis C virus: an update. Arch Med Sci 2020;16:1360-9. [PMID: 33224335 DOI: 10.5114/aoms.2019.83644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Rajhi M, Haddad-Boubaker S, Chouikha A, Bourquain D, Michel J, Hammami W, Sadraoui A, Touzi H, Ghedira K, Triki H. Identification of two novel hepatitis C virus subtype 2 from Tunisia (2v and 2w). PLoS One 2021;16:e0248249. [PMID: 33705445 DOI: 10.1371/journal.pone.0248249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Rajhi M, Ghedira K, Chouikha A, Djebbi A, Cheikh I, Ben Yahia A, Sadraoui A, Hammami W, Azouz M, Ben Mami N, Triki H. Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa. PLoS One 2016;11:e0153761. [PMID: 27100294 DOI: 10.1371/journal.pone.0153761] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Ramia S, Melhem NM, Kreidieh K. Hepatitis C virus infection in the Middle East and North Africa “MENA” region: injecting drug users (IDUs) is an under-investigated population. Infection. 2012;40:1-10. [PMID: 22237470 DOI: 10.1007/s15010-011-0236-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
21 Souii A, Elargoubi A, Fallecker C, Mastouri M, Drouet E. Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping. Curr Microbiol 2016;73:324-34. [PMID: 27189386 DOI: 10.1007/s00284-016-1064-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Sci World J. 2012;2012:719494. [PMID: 22629189 DOI: 10.1100/2012/719494] [Cited by in Crossref: 31] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
23 Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016;16:e35558. [PMID: 27274353 DOI: 10.5812/hepatmon.35558] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]